J&J Creates Space at Janssen Labs for Life Sciences Entrepreneurs

2/5/13

(Page 3 of 3)

safety of clinical trials.

CEO: Yesh Subramanian

Everist Genomics, Ann Arbor, MI: Developing diagnostics, prognostics, and therapeutic selection technologies for cancer and cardiovascular disease.

Chairman: Thomas Everist

Glycosensors and Diagnostics, Athens, GA: Provides enabling technologies for applications in glycoscience.

President: Robert Woods; Chief Scientific Officer; Lori Yang

Linnaeus Bioscience, San Diego: Developing a novel method for identifying and characterizing antibiotics.

Co-Founders: Joe and Kit Pogliano

Misfolding Diagnostics, San Diego: Researching biomarkers and companion diagnostics for protein amyloid diseases.

Leadership: Undisclosed

NeuroGeneration, Los Angeles, CA: Developing neural stem cell products targeting neurological disorders caused by cell loss or injury.

Founder & CEO: Michel F. Levesque

Neurolixis, San Diego: Developing small molecule compounds for treatment-resistant depression, and other CNS diseases and disorders.

Chief Scientific Officer: Adrian Newman-Tancredi

Renascions, San Diego: Working to improve clinical trial outcomes by optimizing patient recruitment, thereby potentially improving drug efficacy.

CEO: Henry Pan

Sialix, Inc., San Diego: Developing products for illnesses associated with non-human sialic acids.

CEO: Jeffrey Behrens

Silicon Biosystems, Bologna, Italy: Proprietary lab-on-a-chip technology to identify, manipulate, and sort specific cells within a heterogeneous population.

CEO: Giuseppe Giorgini

VLP Biotech, San Diego: Developing proprietary technologies to enhance T-cell response to vaccines.

Founder & CEO: Dave Milich; President: Yemi Onakunle

Wellspring Biosciences, San Diego: Discovering and developing small molecule drugs that target signal transduction networks.

CEO: Troy Wilson

Wibi+Works, LLC, New Orleans, LA: Developing uniform and predictable cell-based therapies for diseases associated with inflammation.

Founder and CSO: Aline M. Betancourt; CEO and Medical Director: Ruth S. Waterman

Yolia Health, Mexico City, Mexico: Developing a non-invasive treatment for presbyopia that improves vision by safely modifying the cornea.

Founder & CEO: Alberto Osio

Juliet Preston is a San Diego science writer. Follow @

Single Page Currently on Page: 1 2 3 previous page

By posting a comment, you agree to our terms and conditions.

  • John

    Dear friends,

    I wanted to let you know about a new petition I created on We the People,
    a new feature on WhiteHouse.gov, and ask for your support. Will you add your
    name to mine? If this petition gets 25,000 signatures by February 09, 2013,
    the White House will review it and respond!

    We the People allows anyone to create and sign petitions asking the Obama
    Administration to take action on a range of issues. If a petition gets
    enough support, the Obama Administration will issue an official response.

    You can view and sign the petition here:

    http://wh.gov/Pw20